Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Legrand

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
Frontiers in Bioengineering and Biotechnology|May 10, 2021
Functional Diversity Facilitates Stability Under Environmental Changes in an Outdoor Microalgal Cultivation SystemLina Mattsson, Eva Sörenson, Eric Capo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesotheliomaAndrew Bottomley, Corneel Coens, Fabio Efficace, et al.
Cancer Medicine|April 27, 2019
DNA alteration-based classification of uveal melanoma gives better prognostic stratification than immune infiltration, which has a neutral effect in high-risk groupDeepti Narasimhaiah, Catherine Legrand, Diane Damotte, et al.
Environmental Microbiology|November 19, 2014
Disentangling seasonal bacterioplankton population dynamics by high-frequency samplingMarkus V Lindh, Johanna Sjöstedt, Anders F Andersson, et al.
Clinical Trials (London, England)|March 17, 2006
Heterogeneity in disease free survival between centers: lessons learned from an EORTC breast cancer trialCatherine Legrand, Luc Duchateau, Richard Sylvester, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup StudyAndrew Bottomley, Rabab Gaafar, Rabab Gaafa, et al.
European Journal of Anaesthesiology|September 28, 2011
Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer?Patrice Forget, Bertrand Tombal, Jean-Louis Scholtès, et al.
Frontiers in Microbiology|October 10, 2022
Seasonal Dynamics in Carbon Cycling of Marine Bacterioplankton Are Lifestyle DependentSandra Martínez-García, Carina Bunse, Benjamin Pontiller, et al.
Plos One|January 10, 2020
Deficiency syndromes in top predators associated with large-scale changes in the Baltic Sea ecosystemSanna Majaneva, Emil Fridolfsson, Michele Casini, et al.
Environmental Microbiology|September 1, 2023
Ecophysiological analysis reveals distinct environmental preferences in closely related Baltic Sea picocyanobacteriaAnabella Aguilera, Javier Alegria Zufia, Laura Bas Conn, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
Frontiers in Bioengineering and Biotechnology|May 10, 2021
Functional Diversity Facilitates Stability Under Environmental Changes in an Outdoor Microalgal Cultivation SystemLina Mattsson, Eva Sörenson, Eric Capo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesotheliomaAndrew Bottomley, Corneel Coens, Fabio Efficace, et al.
Cancer Medicine|April 27, 2019
DNA alteration-based classification of uveal melanoma gives better prognostic stratification than immune infiltration, which has a neutral effect in high-risk groupDeepti Narasimhaiah, Catherine Legrand, Diane Damotte, et al.
Environmental Microbiology|November 19, 2014
Disentangling seasonal bacterioplankton population dynamics by high-frequency samplingMarkus V Lindh, Johanna Sjöstedt, Anders F Andersson, et al.
Clinical Trials (London, England)|March 17, 2006
Heterogeneity in disease free survival between centers: lessons learned from an EORTC breast cancer trialCatherine Legrand, Luc Duchateau, Richard Sylvester, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2006
Short-term treatment-related symptoms and quality of life: results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup StudyAndrew Bottomley, Rabab Gaafar, Rabab Gaafa, et al.
European Journal of Anaesthesiology|September 28, 2011
Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer?Patrice Forget, Bertrand Tombal, Jean-Louis Scholtès, et al.
Frontiers in Microbiology|October 10, 2022
Seasonal Dynamics in Carbon Cycling of Marine Bacterioplankton Are Lifestyle DependentSandra Martínez-García, Carina Bunse, Benjamin Pontiller, et al.
Plos One|January 10, 2020
Deficiency syndromes in top predators associated with large-scale changes in the Baltic Sea ecosystemSanna Majaneva, Emil Fridolfsson, Michele Casini, et al.
Environmental Microbiology|September 1, 2023
Ecophysiological analysis reveals distinct environmental preferences in closely related Baltic Sea picocyanobacteriaAnabella Aguilera, Javier Alegria Zufia, Laura Bas Conn, et al.
Pageof 11